Magdalena Dzikowiec , Sandra Galant , Przemysław Lik , Katarzyna Góralska , Dariusz Nejc , Janusz Piekarski , Alicja Majos , Ewa Brzeziańska-Lasota , Dorota Pastuszak-Lewandoska
{"title":"分析幽门螺旋杆菌感染和未感染幽门螺旋杆菌的胃癌患者体内精胺氧化酶基因和促炎细胞因子的表达--一项在波兰人群中开展的试点研究。","authors":"Magdalena Dzikowiec , Sandra Galant , Przemysław Lik , Katarzyna Góralska , Dariusz Nejc , Janusz Piekarski , Alicja Majos , Ewa Brzeziańska-Lasota , Dorota Pastuszak-Lewandoska","doi":"10.1016/j.advms.2024.09.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Many types of cancer have infectious origins. Gastric cancer patients can demonstrate high seroprevalence of <em>Helicobacter pylori</em> (<em>H. pylori</em>). The aim of the present study was to assess the expression of <em>SMOX</em> gene in the group of Polish patients with gastric cancer. <em>SMOX</em> is believed to promote <em>H. pylori</em>-induced carcinogenesis via inflammation, DNA damage and activation of β-catenin signaling. We also assessed the mRNA expression of selected pro-inflammatory cytokines, i.e. <em>IL-2, IFN-γ, TNF-α</em>, and antimicrobial peptide, cathelicidin.</div></div><div><h3>Materials/methods</h3><div>The study material consisted of gastric tissue samples collected during total gastrectomy from three different places in stomach: from primary tumor, 3 cm away from the primary lesion, and from the wall opposite to the primary tumor. After RNA isolation, qPCR reactions were performed for the relevant genes.</div></div><div><h3>Results</h3><div>The obtained results confirmed an increased level of <em>SMOX</em> expression in gastric cancer patients with the history of <em>H. pylori</em> infection. And, as far as we know, this is the first study on <em>SMOX</em> gene expression conducted on tissue taken from a patient, not on a cell line. The levels of pro-inflammatory cytokines, i.e. <em>IL-2, IFN-γ, TNF-α</em>, were also increased, thus indicating their contribution to the specific inflammatory microenvironment of the tumor. Interestingly, the levels of <em>CAMP</em>, encoding antimicrobial peptide, were reduced in all tissue types.</div></div><div><h3>Conclusions</h3><div>The findings confirm that <em>SMOX</em> plays a role in gastric carcinogenesis. However, further research is needed on the role of inflammatory and other factors involved in this process to identify targets for cancer immunotherapy.</div></div>","PeriodicalId":7347,"journal":{"name":"Advances in medical sciences","volume":"69 2","pages":"Pages 443-450"},"PeriodicalIF":2.5000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Analysis of Spermine Oxidase gene and proinflammatory cytokines expression in gastric cancer patients with and without Helicobacter pylori infection – A pilot study in Polish population\",\"authors\":\"Magdalena Dzikowiec , Sandra Galant , Przemysław Lik , Katarzyna Góralska , Dariusz Nejc , Janusz Piekarski , Alicja Majos , Ewa Brzeziańska-Lasota , Dorota Pastuszak-Lewandoska\",\"doi\":\"10.1016/j.advms.2024.09.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><div>Many types of cancer have infectious origins. Gastric cancer patients can demonstrate high seroprevalence of <em>Helicobacter pylori</em> (<em>H. pylori</em>). The aim of the present study was to assess the expression of <em>SMOX</em> gene in the group of Polish patients with gastric cancer. <em>SMOX</em> is believed to promote <em>H. pylori</em>-induced carcinogenesis via inflammation, DNA damage and activation of β-catenin signaling. We also assessed the mRNA expression of selected pro-inflammatory cytokines, i.e. <em>IL-2, IFN-γ, TNF-α</em>, and antimicrobial peptide, cathelicidin.</div></div><div><h3>Materials/methods</h3><div>The study material consisted of gastric tissue samples collected during total gastrectomy from three different places in stomach: from primary tumor, 3 cm away from the primary lesion, and from the wall opposite to the primary tumor. After RNA isolation, qPCR reactions were performed for the relevant genes.</div></div><div><h3>Results</h3><div>The obtained results confirmed an increased level of <em>SMOX</em> expression in gastric cancer patients with the history of <em>H. pylori</em> infection. And, as far as we know, this is the first study on <em>SMOX</em> gene expression conducted on tissue taken from a patient, not on a cell line. The levels of pro-inflammatory cytokines, i.e. <em>IL-2, IFN-γ, TNF-α</em>, were also increased, thus indicating their contribution to the specific inflammatory microenvironment of the tumor. Interestingly, the levels of <em>CAMP</em>, encoding antimicrobial peptide, were reduced in all tissue types.</div></div><div><h3>Conclusions</h3><div>The findings confirm that <em>SMOX</em> plays a role in gastric carcinogenesis. However, further research is needed on the role of inflammatory and other factors involved in this process to identify targets for cancer immunotherapy.</div></div>\",\"PeriodicalId\":7347,\"journal\":{\"name\":\"Advances in medical sciences\",\"volume\":\"69 2\",\"pages\":\"Pages 443-450\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in medical sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1896112624000531\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, RESEARCH & EXPERIMENTAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in medical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1896112624000531","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
Analysis of Spermine Oxidase gene and proinflammatory cytokines expression in gastric cancer patients with and without Helicobacter pylori infection – A pilot study in Polish population
Purpose
Many types of cancer have infectious origins. Gastric cancer patients can demonstrate high seroprevalence of Helicobacter pylori (H. pylori). The aim of the present study was to assess the expression of SMOX gene in the group of Polish patients with gastric cancer. SMOX is believed to promote H. pylori-induced carcinogenesis via inflammation, DNA damage and activation of β-catenin signaling. We also assessed the mRNA expression of selected pro-inflammatory cytokines, i.e. IL-2, IFN-γ, TNF-α, and antimicrobial peptide, cathelicidin.
Materials/methods
The study material consisted of gastric tissue samples collected during total gastrectomy from three different places in stomach: from primary tumor, 3 cm away from the primary lesion, and from the wall opposite to the primary tumor. After RNA isolation, qPCR reactions were performed for the relevant genes.
Results
The obtained results confirmed an increased level of SMOX expression in gastric cancer patients with the history of H. pylori infection. And, as far as we know, this is the first study on SMOX gene expression conducted on tissue taken from a patient, not on a cell line. The levels of pro-inflammatory cytokines, i.e. IL-2, IFN-γ, TNF-α, were also increased, thus indicating their contribution to the specific inflammatory microenvironment of the tumor. Interestingly, the levels of CAMP, encoding antimicrobial peptide, were reduced in all tissue types.
Conclusions
The findings confirm that SMOX plays a role in gastric carcinogenesis. However, further research is needed on the role of inflammatory and other factors involved in this process to identify targets for cancer immunotherapy.
期刊介绍:
Advances in Medical Sciences is an international, peer-reviewed journal that welcomes original research articles and reviews on current advances in life sciences, preclinical and clinical medicine, and related disciplines.
The Journal’s primary aim is to make every effort to contribute to progress in medical sciences. The strive is to bridge laboratory and clinical settings with cutting edge research findings and new developments.
Advances in Medical Sciences publishes articles which bring novel insights into diagnostic and molecular imaging, offering essential prior knowledge for diagnosis and treatment indispensable in all areas of medical sciences. It also publishes articles on pathological sciences giving foundation knowledge on the overall study of human diseases. Through its publications Advances in Medical Sciences also stresses the importance of pharmaceutical sciences as a rapidly and ever expanding area of research on drug design, development, action and evaluation contributing significantly to a variety of scientific disciplines.
The journal welcomes submissions from the following disciplines:
General and internal medicine,
Cancer research,
Genetics,
Endocrinology,
Gastroenterology,
Cardiology and Cardiovascular Medicine,
Immunology and Allergy,
Pathology and Forensic Medicine,
Cell and molecular Biology,
Haematology,
Biochemistry,
Clinical and Experimental Pathology.